103 related articles for article (PubMed ID: 18455747)
1. Effect of transcription peptide inhibitors on HIV-1 replication.
Van Duyne R; Cardenas J; Easley R; Wu W; Kehn-Hall K; Klase Z; Mendez S; Zeng C; Chen H; Saifuddin M; Kashanchi F
Virology; 2008 Jul; 376(2):308-22. PubMed ID: 18455747
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 virus replication using small soluble Tat peptides.
Agbottah E; Zhang N; Dadgar S; Pumfery A; Wade JD; Zeng C; Kashanchi F
Virology; 2006 Feb; 345(2):373-89. PubMed ID: 16289656
[TBL] [Abstract][Full Text] [Related]
3. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
Liang C; Wainberg MA
AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription.
Ivanov A; Lin X; Ammosova T; Ilatovskiy AV; Kumari N; Lassiter H; Afangbedji N; Niu X; Petukhov MG; Nekhai S
Retrovirology; 2018 May; 15(1):39. PubMed ID: 29792216
[TBL] [Abstract][Full Text] [Related]
5. Recent status of HIV-1 gene expression inhibitors.
Baba M
Antiviral Res; 2006 Sep; 71(2-3):301-6. PubMed ID: 16488488
[TBL] [Abstract][Full Text] [Related]
6. Cyclin K/CPR4 inhibits primate lentiviral replication by inactivating Tat/positive transcription elongation factor b-dependent long terminal repeat transcription.
Urano E; Shimizu S; Futahashi Y; Hamatake M; Morikawa Y; Takahashi N; Fukazawa H; Yamamoto N; Komano J
AIDS; 2008 May; 22(9):1081-3. PubMed ID: 18520353
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection.
Devadas K; Boykins RA; Hewlett IK; Wood OL; Clouse KA; Yamada KM; Dhawan S
Peptides; 2007 Mar; 28(3):496-504. PubMed ID: 17188401
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex.
Shimizu S; Urano E; Futahashi Y; Miyauchi K; Isogai M; Matsuda Z; Nohtomi K; Onogi T; Takebe Y; Yamamoto N; Komano J
AIDS; 2007 Mar; 21(5):575-82. PubMed ID: 17314519
[TBL] [Abstract][Full Text] [Related]
9. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
Faller E; Kakal J; Kumar R; Macpherson P
Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
[TBL] [Abstract][Full Text] [Related]
10. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription.
Das AT; Harwig A; Vrolijk MM; Berkhout B
J Virol; 2007 Jul; 81(14):7742-8. PubMed ID: 17494072
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives.
Stevens M; Balzarini J; Lagoja IM; Noppen B; François K; Van Aerschot A; Herdewijn P; De Clercq E; Pannecouque C
Virology; 2007 Aug; 365(1):220-37. PubMed ID: 17459445
[TBL] [Abstract][Full Text] [Related]
12. Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcription.
Kumari N; Iordanskiy S; Kovalskyy D; Breuer D; Niu X; Lin X; Xu M; Gavrilenko K; Kashanchi F; Dhawan S; Nekhai S
Antimicrob Agents Chemother; 2014 Nov; 58(11):6558-71. PubMed ID: 25155598
[TBL] [Abstract][Full Text] [Related]
13. Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription.
Van Duyne R; Guendel I; Jaworski E; Sampey G; Klase Z; Chen H; Zeng C; Kovalskyy D; El Kouni MH; Lepene B; Patanarut A; Nekhai S; Price DH; Kashanchi F
J Mol Biol; 2013 Feb; 425(4):812-29. PubMed ID: 23247501
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription.
Ammosova T; Berro R; Jerebtsova M; Jackson A; Charles S; Klase Z; Southerland W; Gordeuk VR; Kashanchi F; Nekhai S
Retrovirology; 2006 Nov; 3():78. PubMed ID: 17083724
[TBL] [Abstract][Full Text] [Related]
15. Interactions of cell penetrating peptide Tat with model membranes: a biophysical study.
Dennison SR; Baker RD; Nicholl ID; Phoenix DA
Biochem Biophys Res Commun; 2007 Nov; 363(1):178-82. PubMed ID: 17854767
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
Kaproth-Joslin KA; Li X; Reks SE; Kelley GG
Biochem J; 2008 Nov; 415(3):439-48. PubMed ID: 18588506
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of both mesothelioma cell growth and Cdk4 activity following treatment with a TATp16INK4a peptide.
Frizelle SP; Kratzke MG; Carreon RR; Engel SC; Youngquist L; Klein MA; Fourre L; Shekels LL; Kratzke RA
Anticancer Res; 2008; 28(1A):1-7. PubMed ID: 18383817
[TBL] [Abstract][Full Text] [Related]
18. A novel peptide from alpha5 helix of Asterina pectinifera cyclin B conjugated to HIV-Tat(49-57) with cytotoxic and apoptotic effects against human cancer cells.
Lou H; Gao Y; Zhai M; Qi Y; Chen L; Lv H; Yu J; Li Y
Bioorg Med Chem Lett; 2008 Aug; 18(16):4633-7. PubMed ID: 18656352
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
20. Regulation of HIV-1 transcription at 3% versus 21% oxygen concentration.
Charles S; Ammosova T; Cardenas J; Foster A; Rotimi J; Jerebtsova M; Ayodeji AA; Niu X; Ray PE; Gordeuk VR; Kashanchi F; Nekhai S
J Cell Physiol; 2009 Nov; 221(2):469-79. PubMed ID: 19626680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
